RRM2 is implicated in the progression of various cancers, including breast cancer, lung cancer, liver cancer, kidney cancer, glioma, and pancreatic cancer, among others (71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81). This evidence concerns the gene RRM2 and central nervous system cancer.